SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 27th, 2018 • Icad Inc • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 20, 2018, between iCAD, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 27th, 2018 • Icad Inc • Surgical & medical instruments & apparatus
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
SUBSIDIARY GUARANTEESubsidiary Guarantee • December 27th, 2018 • Icad Inc • Surgical & medical instruments & apparatus • New York
SUBSIDIARY GUARANTEE, dated as of December 20, 2018 (this “Guarantee”), made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the purchasers signatory (together with their permitted assigns, the “Purchasers”) to that certain Securities Purchase Agreement, dated as of the date hereof, between iCAD, Inc., a Delaware corporation (the “Company”) and the Purchasers.
5% CONVERTIBLE DEBENTURE DUE DECEMBER 21, 2021Icad Inc • December 27th, 2018 • Surgical & medical instruments & apparatus • New York
THIS 5% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 5% Convertible Debentures of iCAD, Inc., a Delaware corporation (the “Company”), having its principal place of business at 98 Spit Brook Road, Suite 100, Nashua, New Hampshire 03062, designated as its 5% Convertible Debenture due December ___, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
THIRD LOAN MODIFICATION AGREEMENTThird Loan Modification Agreement • December 27th, 2018 • Icad Inc • Surgical & medical instruments & apparatus
This Third Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of December 20, 2018, by and among (a) SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and (b)(i) ICAD, INC., a Delaware corporation (“ICAD”), (ii) XOFT, INC., a Delaware corporation (“Xoft”) and (iii) XOFT SOLUTIONS, LLC, a Delaware limited liability company (“Xoft Solutions”, and together with ICAD and Xoft, individually and collectively, jointly and severally, “Borrower”) whose address is 98 Spit Brook Road, Suite 100, Nashua, New Hampshire 03062.
